瑞士破裂腹主动脉瘤患者的院际转运
该研究基于瑞士联邦统计局2009—2018年病例相关住院数据,分析院际转运与破裂腹主动脉瘤患者院内死亡率的关系。共1798例,27.1%发生院际转运,总体粗院内死亡率为50.3%。院际转运与直接入院相比生存更好(OR 0.52;95%CI 0.36-0.75;p<.001)。
要点
- 在瑞士高度专业化的救援链中,血流动力学稳定的破裂腹主动脉瘤患者转运可能是安全的。
- 院际转运与直接入院相比,院内死亡风险更低(OR 0.52;95%CI 0.36-0.75;p<.001)。
- 与大学医院相比,大型医院治疗与显著更高的死亡率相关(OR 1.98;95%CI 1.41-2.79;p<.001)。
核心结论
- 在瑞士这样具有高度专业化救援链的医疗体系中,血流动力学稳定的破裂腹主动脉瘤患者转运可能是安全的。
- 在此背景下,集中化医疗可能超过因患者转运造成短暂延迟的潜在劣势。
- 需要进一步研究以探讨潜在的混杂因素,如血流动力学和解剖学特征。
研究设计与样本
- 研究为对瑞士联邦统计局2009—2018年病例相关住院出院数据的二次数据分析。
- 纳入所有以破裂腹主动脉瘤为主要或次要诊断的病例。
- 排除以破裂腹主动脉瘤为次要诊断且未接受手术治疗的病例,以及在转诊医院未接受手术治疗即转至另一医院的病例。
- 采用逻辑回归模型分析院内死亡率,自变量包括年龄、性别、入院类型、van Walraven合并症评分、治疗类型、保险等级、医院级别和治疗年份。
主要发现
- 2009年1月1日至2018年12月31日期间,瑞士共有1798例破裂腹主动脉瘤病例接受手术治疗(62.5%)或姑息治疗(37.5%)。
- 72.9%的病例在首次就诊医院直接接受治疗(手术或姑息治疗),而27.1%的破裂腹主动脉瘤病例发生院际转运。
- 总体粗院内死亡率为50.3%;手术治疗队列为23.1%,姑息治疗队列为95.7%。
- 与直接入院患者相比,院际转运与更好的生存相关(OR 0.52;95%CI 0.36-0.75;p<.001)。
- 与大学医院相比,大型医院治疗与显著更高的死亡率相关(OR 1.98;95%CI 1.41-2.79;p<.001)。
局限性
- 需要进一步研究以探讨潜在的混杂因素,如血流动力学和解剖学特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyse the association between inter-hospital transfer and hospital mortality in patients with ruptured abdominal aortic aneurysms (rAAA) in Switzerland. METHODS: Secondary data analysis of case related hospital discharge data from the Swiss Federal Statistical Office for the years 2009 - 2018. All cases with rAAA as primary or secondary diagnosis were included. Cases with rAAA as a secondary diagnosis without surgical treatment and cases that had been transferred to another hospital without surgical treatment at the referring hospital were excluded. Logistic regression models for hospital mortality were constructed with age, sex, type of admission, van Walraven comorbidity score, type of treatment, insurance class, hospital level, and year of treatment as independent variables. RESULTS: A total of 1 798 cases with rAAA were treated either surgically (62.5%) or palliatively (37.5%) in Switzerland from 1 January 2009 to 31 December 2018. Of these cases, 72.9% were treated directly (surgically or palliatively) at the hospital of first presentation, whereas 27.1% of all cases with rAAA were transferred between hospitals. The overall crude hospital mortality was 50.3%; being 23.1% in the surgically treated cohort and 95.7% in the palliatively treated cohort. Inter-hospital transfer was associated with better survival compared with patients who were admitted directly (OR 0.52; 95% CI 0.36 - 0.75; p < .001). Treatment in major hospitals was associated with significantly higher mortality rate compared with university hospitals (OR 1.98; 1.41 - 2.79; p < .001). There was no evidence of an association between open repair and hospital mortality (OR 1.06; 0.77 - 1.48; p = .72) compared with endovascular repair. CONCLUSION: In a healthcare system such as Switzerland's with a highly specialised rescue chain, transfer of haemodynamically stable patients with rAAA is probably safe. In this setting, centralised medical care might outweigh the potential disadvantages of a short delay due to patient transfer. Further studies are needed to address potential confounding factors such as haemodynamic and anatomical features.
引用
- Meuli L, Menges AL, Stoklasa K, et al. Inter-Hospital Transfer of Patients With Ruptured Abdominal Aortic Aneurysm in Switzerland. Eur J Vasc Endovasc Surg. 2022. PMID: 36529366. doi:10.1016/j.ejvs.2022.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。